CClinicalTrials.gg
CompletedNCT04811989Updated May 19, 2022

Educational Interventions on Diabetic Foot Care

An interventional study of Instructive video on diabetic foot care and Informative leaflet with real-time guided reading in Diabetes Mellitus and Diabetic Foot, sponsored by University of Minho. Completed at 2 sites in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-19.

Sponsored by University of Minho · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
71
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Diabetes mellitus currently affects 463 million people worldwide. One of the most serious complications of diabetes is the diabetic foot. Adequate foot care behaviours reduce the risk of ulcers, infections, and amputations, and improve the quality of life, in these patients.

This Pragmatic Randomized Controlled Trial aims to analyse the impact of different educational strategies - an instructive video (Video Watching Group - Experimental Group 1) compared with a leaflet on foot care with real-time guided reading (Real-Time Leaflet Reading Group - Experimental Group 2) and with standard teaching on diabetic foot care (Standard Care - Control Group) - on adherence and knowledge regarding diabetic foot care, as well as on patient's perception of their foot health. Participants will be assessed at the first consultation of the diabetic foot (T0), about two weeks after the first assessment (T1), and three months after the T0 in a follow-up assessment (T2), with T1 and T2 being performed through telephone calls, after obtaining the patients' consent.

The results of the present study will inform educational interventions regarding foot care adherence in patients with diabetic foot, in order to decrease the likelihood of developing diabetic foot ulcers and, consequently, to reduce amputation rates and the several associated costs, contributing to improving patients' quality of life.

Read the detailed description

Specific Aims

  1. To analyze the contribution of sociodemographic, clinical, and psychological variables to diabetic foot care adherence and knowledge, and perceived foot health, over time.
  2. To analyze the differences between groups over time in diabetic foot care adherence, knowledge on foot care, and perceived foot health.
  3. To examine the mediating role of representations about diabetic foot in the relationship between knowledge about foot care and adherence to diabetic foot care, over time, controlling for health literacy.
  4. To examine the moderating role of foot pain, foot function, and footwear between representations about diabetic foot and adherence to diabetic foot care/ perceived foot health, over time.

Data Analysis:

Generalized Mixed Models, which allow examining changes over time including longitudinal mediation and moderation.

Sample size calculation:

Considering a dropout rate of 10%, the sample size required is 60 patients (20 per group).

Procedure:

Participants will be assessed at the first consultation of the diabetic foot (T0), about two weeks after the first assessment (T1), and three months after the T0 in a follow-up assessment (T2), with T1 and T2 being performed through telephone calls.

02

Conditions studied

  • Diabetes Mellitus
  • Diabetic Foot

Browse trials for

Keywords

  • Education
  • Foot care adherence
  • Foot health
  • Knowledge
  • Illness representations
  • Health literacy
  • Video-based intervention
  • Informative Leaflet
03

In context

Diabetic Foot

1,054 studies on the registry are indexed under Diabetic Foot; 222 are open to participants now.

This study's enrollment of 71 is above the median of 60 across 826 interventional studies indexed under Diabetic Foot.

Browse Diabetic Foot studies →

Lead sponsor

University of Minho is the lead sponsor of 37 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of Diabetes mellitus;
  • Diagnosis of Diabetic Foot;
  • To benefit from the first assessment and follow-up at the Multidisciplinary Diabetic Foot Consultation of the hospitals where data collection will take place.

Exclusion criteria

Exclusion Criteria:

  • Presence of clinical dementia described in the patient's clinical record;
  • Cognitive disability to answer the questionnaires;
  • Severe visual and/or hearing impairment.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
71 participants (actual)

Study arms

  • Experimental
    Video Watching Group

    Participants will watch an instructive video on diabetic foot care and will receive face-to-face teaching on diabetic foot care.

    Behavioral: Instructive video on diabetic foot care · Behavioral: Face-to-face teaching

  • Experimental
    Real-time Leaflet Reading Group

    Participants will receive a leaflet with diabetic foot care information, whose reading will be guided in real-time by the Researcher, and will also receive face-to-face teaching on diabetic foot care.

    Behavioral: Informative leaflet with real-time guided reading · Behavioral: Face-to-face teaching

  • Active comparator
    Standard Care Group

    Participants will receive the standard care that includes face-to-face teaching about diabetic foot care and will take a leaflet on diabetic foot care to read at home.

    Behavioral: Informative leaflet to read at home · Behavioral: Face-to-face teaching

Interventions

  • BehavioralInstructive video on diabetic foot care

    In the video, the diabetic foot care is presented verbally and appropriately captioned, as well as exemplified by real patients and health professionals from the hospital

  • BehavioralInformative leaflet with real-time guided reading

    The leaflet has information about diabetic foot care. Researcher will guide its reading with patients.

  • BehavioralInformative leaflet to read at home

    Patients receive a leaflet about diabetic foot care to read at home.

  • BehavioralFace-to-face teaching

    Face-to-face teaching includes the teaching about diabetic foot care during the consultation by health professionals.

06

What researchers measure

Primary outcomes

  1. Adherence to the diabetic foot care behaviours

    Adherence to foot care behaviors will be assessed through the Nottingham Assessment of Functional Foot Care (Lincoln, Jeffcoate, Ince, Smith, \& Radford, 2007). Composed of 29 items whose answers are given on a Likert scale ranging from 0 to 3. Higher scores correspond to a higher frequency of foot care behaviors.

    Time frame: Changes from baseline to two weeks post-test and after a three month follow-up

  2. Adherence to the diabetic foot care behaviours

    The level of foot self-care (indirect measure of adherence) will be assessed through the subscale of Foot Care of the Summary Diabetes Self-Care Activities Questionnaire (Original Version by Toobert, Hampson, \& Glasgow, 2000; Portuguese Version by Bastos, Severo, \& Lopes, 2007). Composed of 3 items in which patients are asked how many of the last seven days did they perform the respective foot care behaviour. Therefore, answers are given on a scale between 0 and 7, and its score is calculated through the mean number of days. Higher scores indicate higher levels of foot self-care.

    Time frame: Changes from baseline to two weeks post-test and after a three month follow-up

  3. Knowledge on foot care

    Knowledge on foot care will be assessed through the Questionnaire on Knowledge of Foot Care (Hasnain \& Sheikh, 2009). Each correct answer is scored with 1 point and higher scores indicate better knowledge about foot care.

    Time frame: Changes from baseline to two weeks post-test and after a three month follow-up

  4. General foot health

    General foot health will be assessed through the respective subscale of the Foot Health Status Questionnaire (FHSQ; Bennett, Patterson, Wearing, \& Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to the perception of poor foot health state/condition and 100 to the perception of excellent foot health.

    Time frame: Changes from baseline to two weeks post-test and after a three month follow-up

Secondary outcomes

  1. Representations about diabetic foot

    Representations about diabetic foot will be assessed through the Illness Perception Questionnaire - Brief (IPQ-B; Figueiras et al., 2010). The response scale ranges from 0 to 10. Higher scores indicate more threatening representations regarding diabetic foot.

    Time frame: Changes from baseline to two weeks post-test and after a three month follow-up

Other outcomes

  1. Foot pain

    Foot pain will be assessed through the respective subscale of the Foot Health Status Questionnaire (Bennett, Patterson, Wearing, \& Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to significant or extreme foot pain and 100 to no foot pain or discomfort.

    Time frame: Baseline (T0), two weeks post-test (T1), three months follow-up (T2)

  2. Foot function

    Foot function will be assessed through the respective subscale of the Foot Health Status Questionnaire (FHSQ; Bennett, Patterson, Wearing, \& Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to severe limitation in the performance of physical activities because of the feet and 100 to no limitation.

    Time frame: Baseline (T0), two weeks post-test (T1), three months follow-up (T2)

  3. Footwear

    Footwear will be assessed through the respective subscale of the Foot Health Status Questionnaire (FHSQ; Bennett, Patterson, Wearing, \& Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to severe problems obtaining appropriate footwear and 100 to no problems.

    Time frame: Baseline (T0), two weeks post-test (T1), three months follow-up (T2)

  4. Clinical Data

    Clinical variables (e.g., HbA1c levels, presence/absence of active ulcer and duration of diabetic foot ulcer, recommendation to use therapeutic footwear) will be assessed through a Clinical Questionnaire developed for this study

    Time frame: Baseline (T0)

  5. Health literacy

    Health literacy will be assessed through the Medical Term Recognition Test (METER; Paiva et al., 2014).

    Time frame: Baseline (T0)

  6. Sociodemographic data

    The sample will be characterized using a Sociodemographic Questionnaire developed for this study (e.g. age, marital status, gender, socio-economic level).

    Time frame: Baseline (T0)

07

Study locations

2 sites
  • Clínica do Pé Diabético, Centro Hospitalar do Tâmega e Sousa
    Penafiel, Porto 4564-007, Portugal
  • Centro Hospitalar Universitário do Porto
    Porto, 4099-001, Portugal
08

References and documents

Publications

  • Bastos F, Severo M, Lopes C. [Psychometric analysis of diabetes self-care scale (translated and adapted to Portuguese)]. Acta Med Port. 2007 Jan-Feb;20(1):11-20. Epub 2007 May 23. Portuguese. PubMed 17624279 ↗
  • Bennett PJ, Patterson C, Wearing S, Baglioni T. Development and validation of a questionnaire designed to measure foot-health status. J Am Podiatr Med Assoc. 1998 Sep;88(9):419-28. doi: 10.7547/87507315-88-9-419. PubMed 9770933 ↗
  • Figueiras M, Marcelino DS, Claudino A, Cortes MA, Maroco J, Weinman J. Patients' illness schemata of hypertension: the role of beliefs for the choice of treatment. Psychol Health. 2010 Apr;25(4):507-17. doi: 10.1080/08870440802578961. PubMed 20204931 ↗
  • Hasnain S, Sheikh NH. Knowledge and practices regarding foot care in diabetic patients visiting diabetic clinic in Jinnah Hospital, Lahore. J Pak Med Assoc. 2009 Oct;59(10):687-90. PubMed 19813683 ↗
  • Lincoln, N. B., Jeffcoate, W. J., Ince, P., Smith, M., & Radford, K. A. (2007). Validation of a new measure of protective footcare behaviour: the Nottingham Assessment of Functional Footcare (NAFF). Practical Diabetes International, 24, 207-211. doi:10.1002/pdi.1099
  • Paiva D, Silva S, Severo M, Ferreira P, Santos O, Lunet N, Azevedo A. Cross-cultural adaptation and validation of the health literacy assessment tool METER in the Portuguese adult population. Patient Educ Couns. 2014 Nov;97(2):269-75. doi: 10.1016/j.pec.2014.07.024. Epub 2014 Jul 22. PubMed 25107513 ↗
  • Pandis N. Randomization. Part 3: allocation concealment and randomization implementation. Am J Orthod Dentofacial Orthop. 2012 Jan;141(1):126-8. doi: 10.1016/j.ajodo.2011.09.003. No abstract available. PubMed 22196195 ↗
  • Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000 Jul;23(7):943-50. doi: 10.2337/diacare.23.7.943. PubMed 10895844 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04811989
Lead sponsor
University of Minho
Collaborators
Foundation for Science and Technology, Portugal
Responsible party
Gabriela Ferreira (Principal Investigator, Master, University of Minho) — Principal investigator
First posted
Mar 23, 2021
Start date
Mar 8, 2021
Primary completion
Dec 15, 2021
Completion
Dec 31, 2021
Last update
May 19, 2022

Study contacts

Gabriela Ferreira, Master
principal investigator · School of Psychology, University of Minho

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion